Forget Weight Loss: Eli Lilly's Real Upside Is As An AI Compounder

🇺🇸 Seeking Alpha (US) —
Forget Weight Loss: Eli Lilly's Real Upside Is As An AI Compounder

AI Summary

Eli Lilly's growth prospects are increasingly tied to its use of artificial intelligence for compound discovery rather than solely its weight loss drugs. The integration of AI technology is positioning the company as a significant player in pharmaceutical innovation.

Markets Deals AI & Tech Eli Lilly artificial intelligence pharmaceuticals drug discovery AI compounder market growth

Read original source →